Inflammation, tertiary lymphoid structures, and lung cancer: a bibliometric analysis
This study underscores the pivotal role of inflammation in lung cancer progression, mediated by a delicate balance of immune responses. The emerging prominence of TLS as indicator of adaptive immune responses within the tumor microenvironment (TME) offers intriguing avenues for future research and therapeutic interventions. However, limitations in the current research, such as the need for more longitudinal studies and clinical trials, must be addressed. The insights gained from this bibliometric analysis can inform clinical practices and guide future investigations into novel strategies to improve patient outcomes.
Authors
- Lixuan Lin
- Wenhua Liang (ORCID: https://orcid.org/0000-0002-1391-8238)
- Linchong Huang (ORCID: https://orcid.org/0000-0002-0122-6226)
- Zengfu Liu
- Qi Cai (ORCID: https://orcid.org/0009-0003-8777-311X)
- Xiwen Liu (ORCID: https://orcid.org/0000-0002-0426-6629)
- Huiting Liu (ORCID: https://orcid.org/0000-0002-8572-6876)
- S Zeng
- Jianxing He
- Yang Xiang
Institutions
- First Affiliated Hospital of Guangzhou Medical University (CN)
- State Key Laboratory of Respiratory Disease (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tlcr-24-350
- Citations
- 1
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.28
Funders
- National Natural Science Foundation of China